These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 504342)

  • 1. [A comparative study of the longacting neuroleptics perphenazin-enanthate and fluspirilene (author's transl)].
    Tegeler J; Floru L
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Sep; 12(5):357-65. PubMed ID: 504342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical study on five depot neuroleptics. Comparison of effective profiles of fluphenazinedecanoate, fluspirilene, penfluridol, perphenazine-enanthate and pipothiazinepalmitate].
    Angst J; Woggon B
    Arzneimittelforschung; 1975 Feb; 25(2):267-70. PubMed ID: 1091272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perphenazine decanoate vs. perphenazine enanthate: efficacy and side effects in a 6 week double-blind, comparative study of 50 drug monitored psychotic patients.
    Knudsen P; Hansen LB; Auken G; Waehrens J; Højholdt K; Larsen NE
    Acta Psychiatr Scand Suppl; 1985; 322():15-28. PubMed ID: 3907278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fluspirilen and fluphenazine in schizophrenic patients. Comparative study].
    Magnus RV
    MMW Munch Med Wochenschr; 1980 Dec; 122(49):1758-60. PubMed ID: 6779147
    [No Abstract]   [Full Text] [Related]  

  • 5. A controlled clinical trial of fluspirilene, a long-acting injectable neuroleptic, in schizophrenic patients with acute exacerbation.
    Chouinard G; Annable L; Steinberg S
    J Clin Psychopharmacol; 1986 Feb; 6(1):21-6. PubMed ID: 3512622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term tranquilizers - an alternative in medical practice (author's transl)].
    Pach J; Waniek W
    Arzneimittelforschung; 1976; 26(6):1189-90. PubMed ID: 786318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Double-blind comparison of 2 depot neuroleptics (perphenazine enanthate and flupentixol decanoate) in chronic schizophrenia (author's transl)].
    Eufe R; Wegener G
    Nervenarzt; 1979 Aug; 50(8):534-9. PubMed ID: 394015
    [No Abstract]   [Full Text] [Related]  

  • 8. A double-blind clinical evaluation of different dose intervals with fluspirilene (IMAP).
    Börger J; Van Epen JH; Dekkers A
    Acta Psychiatr Belg; 1978; 78(2):383-91. PubMed ID: 354325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective evaluation of long-term fluspirilene (IMAP) treatment.
    Tanghe A
    Acta Psychiatr Belg; 1976 May; 76(3):480-90. PubMed ID: 1020683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter controlled trial of fluspirilene and fluphenazine enanthate in chronic schizophrenic syndromes.
    Malm U; Perris C; Rapp W; Wedrén G
    Acta Psychiatr Scand Suppl; 1974; 249():94-116. PubMed ID: 4608506
    [No Abstract]   [Full Text] [Related]  

  • 11. [A comparison of the tranquilizing effect of fluspirilene and diazepam (author's transl)].
    Pach J; Waniek W
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Mar; 9(2):61-6. PubMed ID: 981324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug-response differences of high and standard dosage of fluphenazine-decanoate in relation to schizophrenic symptoms (author's transl)].
    Lehmann E; Quadbeck H; Tegeler J; Fararuni M; Heinrich K
    Pharmakopsychiatr Neuropsychopharmakol; 1980 May; 13(3):117-29. PubMed ID: 7393998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experience with fluspirilene in gerontopsychiatry (author's transl)].
    Kanowski S; Paur R
    Pharmakopsychiatr Neuropsychopharmakol; 1980 May; 13(3):137-43. PubMed ID: 7393999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Perphenazine enanthate. Results of a 1-year open multicenter study].
    Baruch P; Brion S; Broussolle P; Gayral LF; Ropert R; Volmat R; Porot M
    Encephale; 1989; 15(5):449-55. PubMed ID: 2686965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The depot neuroleptic agent fluspirilene (author's transl)].
    Angst J; Frei M; Scharfetter Chr
    Pharmakopsychiatr Neuropsychopharmakol; 1973 Jan; 6(1):13-28. PubMed ID: 4602371
    [No Abstract]   [Full Text] [Related]  

  • 16. Fluspirilene in the treatment of chronic schizophrenic outpatients.
    St-Laurent J; Carle R; Domingue D
    Curr Ther Res Clin Exp; 1972 Sep; 14(9):599-608. PubMed ID: 4628682
    [No Abstract]   [Full Text] [Related]  

  • 17. Clopenthixol decanoate and perphenazine enanthate in schizophrenic patients. A double-blind Nordic multicentre trial.
    Ahlfors UG; Dencker SJ; Gravem A; Remvig J
    Acta Psychiatr Scand Suppl; 1980; 279():77-91. PubMed ID: 6996426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind therapeutic evaluation of fluspirilene compared with fluphenazine decanoate in chronic schizophrenics.
    Frangos H; Zissis NP; Leontopoulos I; Diamantas N; Tsitouridis S; Gavriil I; Tsolis K
    Acta Psychiatr Scand; 1978 May; 57(5):436-46. PubMed ID: 354331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term depot neuroleptic treatment with perphenazine decanoate. I. Efficacy and side effects in a 12 month study of 42 drug monitored psychotic patients.
    Knudsen P; Hansen LB; Højholdt K; Larsen NE
    Acta Psychiatr Scand Suppl; 1985; 322():29-40. PubMed ID: 3907279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind comparison of fluspirilene and fluphenazine decanoate in schizophrenia.
    Russell N; Landmark J; Merskey H; Turpin T
    Can J Psychiatry; 1982 Nov; 27(7):593-6. PubMed ID: 7172160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.